Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

MTP inhibitor BMS-201038 in development for hyperlipidemia

April 26, 1996

Colestimide NDA filing imminent

April 26, 1996

Otsuka evaluates hypolipidemic agents

April 26, 1996

Sanofi Winthrop discovers potent ATP-citrate lyase inhibitor

April 26, 1996

NTE-122: Nissin Foods' ACAT inhibitor

April 26, 1996

FemPatch approval imminent in USA

April 19, 1996

FDA designates orphan drug for Peyronie's disease

April 19, 1996

Troglitazone NDA filing expected soon

April 19, 1996

RF-1051 cleared to enter phase II

April 19, 1996

Obesity gene identified

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026